- Home
- DXCM vs KB Comparison
DXCM vs KB Comparison
Compare DXCM & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- KB
- Stock Information
- Founded
- DXCM 1999
- KB 2008
- Country
- DXCM United States
- KB South Korea
- Employees
- DXCM N/A
- KB N/A
- Industry
- DXCM Medical/Dental Instruments
- KB Commercial Banks
- Sector
- DXCM Health Care
- KB Finance
- Exchange
- DXCM Nasdaq
- KB Nasdaq
- Market Cap
- DXCM 28.0B
- KB 22.1B
- IPO Year
- DXCM 2005
- KB N/A
- Fundamental
- Price
- DXCM $80.20
- KB $58.48
- Analyst Decision
- DXCM Buy
- KB
- Analyst Count
- DXCM 17
- KB 0
- Target Price
- DXCM $98.00
- KB N/A
- AVG Volume (30 Days)
- DXCM 3.4M
- KB 281.3K
- Earning Date
- DXCM 02-06-2025
- KB 10-24-2024
- Dividend Yield
- DXCM N/A
- KB 3.83%
- EPS Growth
- DXCM 83.21
- KB 5.68
- EPS
- DXCM 1.67
- KB 8.78
- Revenue
- DXCM $3,954,000,000.00
- KB $10,742,590,155.00
- Revenue This Year
- DXCM $13.10
- KB N/A
- Revenue Next Year
- DXCM $14.74
- KB N/A
- P/E Ratio
- DXCM $48.12
- KB $6.56
- Revenue Growth
- DXCM 16.19
- KB 6.32
- 52 Week Low
- DXCM $62.34
- KB $36.57
- 52 Week High
- DXCM $142.00
- KB $72.89
- Technical
- Relative Strength Index (RSI)
- DXCM 57.98
- KB 35.83
- Support Level
- DXCM $74.50
- KB $58.32
- Resistance Level
- DXCM $80.83
- KB $59.68
- Average True Range (ATR)
- DXCM 2.41
- KB 0.89
- MACD
- DXCM -0.04
- KB -0.06
- Stochastic Oscillator
- DXCM 78.46
- KB 21.11
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About KB KB Financial Group Inc
KB Financial Group Inc is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segment includes the Banking business, Securities business, Non-life Insurance business, Credit card business, and life Insurance business. The Group generates the majority of its revenue from the Banking business.